FRANKFURT (Reuters) - German drugmaker Bayer said it filed for marketing approval in Europe for the use of eye drug Eylea as a treatment of diabetic macular oedema. Bayer has said it expects Eylea, also known as VEGF Trap-Eye, to generate more tha...
Source: http://health.yahoo.net/news/s/nm/bayer-seeks-wider-use-for-eye-drug-eylea-in-europe
website view view site view website
No comments:
Post a Comment
Note: only a member of this blog may post a comment.